Why Is AVEANNA HEALTHCARE H (AVAH) Stock Up Today?

Aveanna Healthcare (AVAH) rose 4.33% to $13.73 on Friday, driven by two recent analyst upgrades that raised price targets. The stock opened with a 1.4% gap up and reached a session high of $13.85 in early trading. The stock has surged nearly 50% over the past eight sessions, reaching a new 52-week high on Friday.

What Happened

Truist and RBC Capital both raised their price targets for Aveanna Healthcare in the past 36 hours. Truist increased its target to $15 from $11 while RBC Capital raised its to $16 from $10. These upgrades came amid a broader market movement where several healthcare stocks saw pre-market activity. Aveanna also recently priced a secondary offering of 15 million shares at $11.75 per share. The stock opened at $13.35, reflecting a gap up from the previous close of $13.16, and has traded in a narrow range throughout the session.

What The Data Shows

The stock is currently trading near its 52-week high of $13.61, having moved from $9.05 to $13.56 in the last eight sessions. With a market cap of $2.9 billion and a P/E ratio of 10.7, the stock has shown strong revenue growth of 19.5% in the trailing twelve months. However, recent insider transactions have shown selling activity, with three insiders collectively selling $214.6 million in shares over the past 90 days. The stock has a beta of 1.93, indicating higher volatility than the market.

What To Watch

Aveanna Healthcare does not have an upcoming earnings date listed. Investors should monitor the breadth of analyst coverage and any further developments in the healthcare sector, as well as the stock’s ability to maintain its current price level amid ongoing insider selling.